Analysis
| Earnings estimate |
Current quarter (Dec 2025) |
Next quarter (Mar 2026) |
Current year (Dec 2025) |
Next year (Dec 2026) |
|---|---|---|---|---|
| Number of analysts | 7 | 2 | 18 | 18 |
| Average estimate | 2.14 | 2.51 | 9.20 | 10.46 |
| Low estimate | 1.92 | 2.51 | 8.95 | 9.95 |
| High estimate | 2.36 | 2.51 | 9.41 | 11.39 |
| Last year EPS | 2.09 | 2.49 | 8.21 | 9.20 |
| Revenue estimate |
Current quarter (Dec 2025) |
Next quarter (Mar 2026) |
Current year (Dec 2025) |
Next year (Dec 2026) |
|---|---|---|---|---|
| Number of Analysts | 9 | 2 | 22 | 22 |
| Avg. estimate | 15.48B | 14.39B | 58.72B | 62.45B |
| Low estimate | 15.18B | 14.34B | 58.13B | 60.26B |
| High estimate | 15.90B | 14.45B | 59.43B | 65.29B |
| Last year sales | 14.89B | 13.59B | 54.07B | 58.72B |
| Sales growth | 0.04 | 0.06 | 0.09 | 0.06 |
| EPS trend |
Current quarter (Dec 2025) |
Next quarter (Mar 2026) |
Current year (Dec 2025) |
Next year (Dec 2026) |
|---|---|---|---|---|
| Current estimate | 2.14 | 2.51 | 9.20 | 10.46 |
| 7 days ago | 2.19 | 2.51 | 9.20 | 10.44 |
| 30 days ago | 2.19 | 2.51 | 9.18 | 10.40 |
| 60 days ago | 2.17 | 2.51 | 9.12 | 10.43 |
| 90 days ago | 2.18 | 0 | 9.10 | 10.45 |
| EPS revisions |
Current quarter (Dec 2025) |
Next quarter (Mar 2026) |
Current year (Dec 2025) |
Next year (Dec 2026) |
|---|---|---|---|---|
| Up last 7 days | 1 | 0 | 4 | 3 |
| Up last 30 days | 1 | 0 | 9 | 8 |
| Down last 7 days | 0 | 0 | 0 | 0 |
| Down last 30 days | 3 | 1 | 4 | 5 |
| Growth estimates | |
|---|---|
| Current qtr (Nov 2025) | 0.026% |
| Next qtr. (Feb 2026) | 0.008% |
| Current year (2025) | 0.121% |
| Next 5 years (per annum) | 0.232% |
| Past 5 years (per annum) | 0.383% |
Recommendation
Buy